The global transdermal patch market is expected to grow at a CAGR of 5.5% during the forecast period, to reach USD 3.2 billion by 2030 from USD 2.4 billion in 2018. The growth of the market is attributed to factors such as increasing awareness about the benefits of transdermal patches, growing number of patients suffering from chronic diseases and increasing demand for transdermal patches in emerging economies such as China and India. Methyl salicylate-based patch segment accounted for the largest share in 2018 owing to its wide range of applications such as relief from pain, smoking cessation and cardiovascular diseases among others. The nicotine-based patch segment is expected to grow at a CAGR of 6% during the forecast period due to its wide range of applications such as smoking cessation and weight management among others.
Some Of The Growth Factors Of This Market:
- The Transdermal Patch market is driven by the increasing prevalence of chronic diseases, such as diabetes and obesity, which are leading to an increase in the demand for transdermal patches.
- Increasing awareness about the benefits of transdermal patches over other drug delivery systems such as oral medications and injections will drive the growth of this market.
- The increasing number of patents on transdermal patch technologies will create opportunities for new players in this market.
- Increasing government funding for research and development activities related to transdermal patches will create opportunities for new players in this market.
Industry Growth Insights published a new data on “Transdermal Patch Market”. The research report is titled “Transdermal Patch Market research by Types (Methyl Salicylate-based Patch, Rivastigmine Transdermal Patch, Fentanyl Transdermal Patch, Nicotine Transdermal Patch, Estradiol Transdermal Patch, Others), By Applications (Relieve Pain, Smoking Stopping, Cardiovascular Diseases, Menopausal Syndrome, Others), By Players/Companies Hisamitsu Pharmaceutical, Johnson & Johnson, Novartis, UCB Pharma, Mylan, Nitto Denko, Teikoku Seiyaku, GSK, Luye Pharma Group, Pfizer, Teva Pharmaceutical, Dr Reddy’s Laboratories, Bayer, Mundipharma, Lohmann Therapie-Systeme, Beijing Tide Pharmaceutical”.
Scope Of The Report
Report Attributes
Report Details
Report Title
Transdermal Patch Market Research Report
By Type
Methyl Salicylate-based Patch, Rivastigmine Transdermal Patch, Fentanyl Transdermal Patch, Nicotine Transdermal Patch, Estradiol Transdermal Patch, Others
By Application
Relieve Pain, Smoking Stopping, Cardiovascular Diseases, Menopausal Syndrome, Others
By Companies
Hisamitsu Pharmaceutical, Johnson & Johnson, Novartis, UCB Pharma, Mylan, Nitto Denko, Teikoku Seiyaku, GSK, Luye Pharma Group, Pfizer, Teva Pharmaceutical, Dr Reddy’s Laboratories, Bayer, Mundipharma, Lohmann Therapie-Systeme, Beijing Tide Pharmaceutical
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
232
Number of Tables & Figures
163
Customization Available
Yes, the report can be customized as per your need.
Global Transdermal Patch Market Report Segments:
The global Transdermal Patch market is segmented on the basis of:
Types
Methyl Salicylate-based Patch, Rivastigmine Transdermal Patch, Fentanyl Transdermal Patch, Nicotine Transdermal Patch, Estradiol Transdermal Patch, Others
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Relieve Pain, Smoking Stopping, Cardiovascular Diseases, Menopausal Syndrome, Others
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Hisamitsu Pharmaceutical
- Johnson & Johnson
- Novartis
- UCB Pharma
- Mylan
- Nitto Denko
- Teikoku Seiyaku
- GSK
- Luye Pharma Group
- Pfizer
- Teva Pharmaceutical
- Dr Reddy’s Laboratories
- Bayer
- Mundipharma
- Lohmann Therapie-Systeme
- Beijing Tide Pharmaceutical
Highlights of The Transdermal Patch Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Methyl Salicylate-based Patch
- Rivastigmine Transdermal Patch
- Fentanyl Transdermal Patch
- Nicotine Transdermal Patch
- Estradiol Transdermal Patch
- Others
- By Application:
- Relieve Pain
- Smoking Stopping
- Cardiovascular Diseases
- Menopausal Syndrome
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Transdermal Patch Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
A transdermal patch is a type of medication that is placed on the skin. It releases the drug into the body through the skin.
Some of the key players operating in the transdermal patch market are Hisamitsu Pharmaceutical, Johnson & Johnson, Novartis, UCB Pharma, Mylan, Nitto Denko, Teikoku Seiyaku, GSK, Luye Pharma Group, Pfizer, Teva Pharmaceutical, Dr Reddy¢â‚¬â„¢s Laboratories, Bayer, Mundipharma, Lohmann Therapie-Systeme, Beijing Tide Pharmaceutical.
The transdermal patch market is expected to grow at a compound annual growth rate of 5.5%.
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Transdermal Patch Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Transdermal Patch Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Transdermal Patch Market - Supply Chain
4.5. Global Transdermal Patch Market Forecast
4.5.1. Transdermal Patch Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Transdermal Patch Market Size (000 Units) and Y-o-Y Growth
4.5.3. Transdermal Patch Market Absolute $ Opportunity
5. Global Transdermal Patch Market Analysis and Forecast by Type
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Type
5.2.2. Y-o-Y Growth Projections by Type
5.3. Transdermal Patch Market Size and Volume Forecast by Type
5.3.1. Methyl Salicylate-based Patch
5.3.2. Rivastigmine Transdermal Patch
5.3.3. Fentanyl Transdermal Patch
5.3.4. Nicotine Transdermal Patch
5.3.5. Estradiol Transdermal Patch
5.3.6. Others
5.4. Absolute $ Opportunity Assessment by Type
5.5. Market Attractiveness/Growth Potential Analysis by Type
6. Global Transdermal Patch Market Analysis and Forecast by Application
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Application
6.2.2. Y-o-Y Growth Projections by Application
6.3. Transdermal Patch Market Size and Volume Forecast by Application
6.3.1. Relieve Pain
6.3.2. Smoking Stopping
6.3.3. Cardiovascular Diseases
6.3.4. Menopausal Syndrome
6.3.5. Others
6.4. Absolute $ Opportunity Assessment by Application
6.5. Market Attractiveness/Growth Potential Analysis by Application
7. Global Transdermal Patch Market Analysis and Forecast by Sales Channel
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Sales Channel
7.2.2. Y-o-Y Growth Projections by Sales Channel
7.3. Transdermal Patch Market Size and Volume Forecast by Sales Channel
7.3.1. Manufacturer/Distributor/Service Provider
7.3.2. Aftermarket
7.4. Absolute $ Opportunity Assessment by Sales Channel
7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel
8. Global Transdermal Patch Market Analysis and Forecast by Region
8.1. Market Trends
8.2. Introduction
8.2.1. Basis Point Share (BPS) Analysis by Region
8.2.2. Y-o-Y Growth Projections by Region
8.3. Transdermal Patch Market Size and Volume Forecast by Region
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. Middle East and Africa (MEA)
8.4. Absolute $ Opportunity Assessment by Region
8.5. Market Attractiveness/Growth Potential Analysis by Region
8.6. Global Transdermal Patch Demand Share Forecast, 2019-2026
9. North America Transdermal Patch Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.2. North America Transdermal Patch Market Size and Volume Forecast by Country
9.2.1. U.S.
9.2.2. Canada
9.3. Absolute $ Opportunity Assessment by Country
9.4. North America Transdermal Patch Market Size and Volume Forecast by Application
9.4.1. Relieve Pain
9.4.2. Smoking Stopping
9.4.3. Cardiovascular Diseases
9.4.4. Menopausal Syndrome
9.4.5. Others
9.5. Basis Point Share (BPS) Analysis by Application
9.6. Y-o-Y Growth Projections by Application
9.7. North America Transdermal Patch Market Size and Volume Forecast by Type
9.7.1. Methyl Salicylate-based Patch
9.7.2. Rivastigmine Transdermal Patch
9.7.3. Fentanyl Transdermal Patch
9.7.4. Nicotine Transdermal Patch
9.7.5. Estradiol Transdermal Patch
9.7.6. Others
9.8. Basis Point Share (BPS) Analysis by Type
9.9. Y-o-Y Growth Projections by Type
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.10.4. By Sales Channel
9.11. North America Transdermal Patch Demand Share Forecast, 2019-2026
10. Latin America Transdermal Patch Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Latin America Average Pricing Analysis
10.2. Latin America Transdermal Patch Market Size and Volume Forecast by Country
10.2.1. Brazil
10.2.2. Mexico
10.2.3. Rest of Latin America
10.3. Absolute $ Opportunity Assessment by Country
10.4. Latin America Transdermal Patch Market Size and Volume Forecast by Application
10.4.1. Relieve Pain
10.4.2. Smoking Stopping
10.4.3. Cardiovascular Diseases
10.4.4. Menopausal Syndrome
10.4.5. Others
10.5. Basis Point Share (BPS) Analysis by Application
10.6. Y-o-Y Growth Projections by Application
10.7. Latin America Transdermal Patch Market Size and Volume Forecast by Type
10.7.1. Methyl Salicylate-based Patch
10.7.2. Rivastigmine Transdermal Patch
10.7.3. Fentanyl Transdermal Patch
10.7.4. Nicotine Transdermal Patch
10.7.5. Estradiol Transdermal Patch
10.7.6. Others
10.8. Basis Point Share (BPS) Analysis by Type
10.9. Y-o-Y Growth Projections by Type
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.10.4. By Sales Channel
10.11. Latin America Transdermal Patch Demand Share Forecast, 2019-2026
11. Europe Transdermal Patch Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Europe Average Pricing Analysis
11.2. Europe Transdermal Patch Market Size and Volume Forecast by Country
11.2.1. Germany
11.2.2. France
11.2.3. Italy
11.2.4. U.K.
11.2.5. Spain
11.2.6. Russia
11.2.7. Rest of Europe
11.3. Absolute $ Opportunity Assessment by Country
11.4. Europe Transdermal Patch Market Size and Volume Forecast by Application
11.4.1. Relieve Pain
11.4.2. Smoking Stopping
11.4.3. Cardiovascular Diseases
11.4.4. Menopausal Syndrome
11.4.5. Others
11.5. Basis Point Share (BPS) Analysis by Application
11.6. Y-o-Y Growth Projections by Application
11.7. Europe Transdermal Patch Market Size and Volume Forecast by Type
11.7.1. Methyl Salicylate-based Patch
11.7.2. Rivastigmine Transdermal Patch
11.7.3. Fentanyl Transdermal Patch
11.7.4 Nicotine Transdermal Patch
11.7.5. Estradiol Transdermal Patch
11.7.6. Others
11.8. Basis Point Share (BPS) Analysis by Type
11.9. Y-o-Y Growth Projections by Type
11.10. Market Attractiveness/Growth Potential Analysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3. By Application
11.10.4. By Sales Channel
11.11. Europe Transdermal Patch Demand Share, 2019-2026
12. Asia Pacific Transdermal Patch Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Asia Pacific Average Pricing Analysis
12.2. Asia Pacific Transdermal Patch Market Size and Volume Forecast by Country
12.2.1. China
12.2.2. Japan
12.2.3. South Korea
12.2.4. India
12.2.5. Australia
12.2.6. Rest of Asia Pacific (APAC)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Asia Pacific Transdermal Patch Market Size and Volume Forecast by Application
12.4.1. Relieve Pain
12.4.2. Smoking Stopping
12.4.3. Cardiovascular Diseases
12.4.4. Menopausal Syndrome
12.4.5. Others
12.5. Basis Point Share (BPS) Analysis by Application
12.6. Y-o-Y Growth Projections by Application
12.7. Asia Pacific Transdermal Patch Market Size and Volume Forecast by Type
12.7.1. Methyl Salicylate-based Patch
12.7.2. Rivastigmine Transdermal Patch
12.7.3. Fentanyl Transdermal Patch
12.7.4. Nicotine Transdermal Patch
12.7.5. Estradiol Transdermal Patch
12.7.6. Others
12.8. Basis Point Share (BPS) Analysis by Type
12.9. Y-o-Y Growth Projections by Type
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.10.4. By Sales Channel
12.11. Asia Pacific Transdermal Patch Demand Share, 2019-2026
13. Middle East & Africa Transdermal Patch Market Analysis and Forecast
13.1. Introduction
13.1.1. Basis Point Share (BPS) Analysis by Country
13.1.2. Y-o-Y Growth Projections by Country
13.1.3. Asia Pacific Average Pricing Analysis
13.2. Middle East & Africa Transdermal Patch Market Size and Volume Forecast by Country
13.2.1. Saudi Arabia
13.2.2. South Africa
13.2.3. UAE
13.2.4. Rest of Middle East & Africa (MEA)
13.3. Absolute $ Opportunity Assessment by Country
13.4. Middle East & Africa Transdermal Patch Market Size and Volume Forecast by Application
13.4.1. Relieve Pain
13.4.2. Smoking Stopping
13.4.3. Cardiovascular Diseases
13.4.4. Menopausal Syndrome
13.4.5. Others
13.5. Basis Point Share (BPS) Analysis by Application
13.6. Y-o-Y Growth Projections by Application
13.7. Middle East & Africa Transdermal Patch Market Size and Volume Forecast by Type
13.7.1. Methyl Salicylate-based Patch
13.7.2. Rivastigmine Transdermal Patch
13.7.3. Fentanyl Transdermal Patch
13.7.4. Nicotine Transdermal Patch
13.7.5. Estradiol Transdermal Patch
13.7.6. Others
13.8. Basis Point Share (BPS) Analysis by Type
13.9. Y-o-Y Growth Projections by Type
13.10. Market Attractiveness/Growth Potential Analysis
13.10.1. By Country
13.10.2. By Product Type
13.10.3. By Application
13.10.4. By Sales Channel
13.11. Middle East & Africa Transdermal Patch Demand Share, 2019-2026
14. Competition Landscape
14.1. Global Transdermal Patch Market: Market Share Analysis
14.2. Transdermal Patch Distributors and Customers
14.3. Transdermal Patch Market: Competitive Dashboard
14.4. Company Profiles (Details Overview, Financials, Developments, Strategy)
14.4.1. Hisamitsu Pharmaceutical
14.4.1.1. Overview
14.4.1.2. Financials
14.4.1.3. Developments
14.4.1.4. Strategic Outlook
14.4.2. Johnson & Johnson
14.4.2.1. Overview
14.4.2.2. Financials
14.4.2.3. Developments
14.4.2.4. Strategic Outlook
14.4.3. Novartis
14.4.3.1. Overview
14.4.3.2. Financials
14.4.3.3. Developments
14.4.3.4. Strategic Outlook
14.4.4. UCB Pharma
14.4.4.1. Overview
14.4.4.2. Financials
14.4.4.3. Developments
14.4.4.4. Strategic Outlook
14.4.5. Mylan
14.4.5.1. Overview
14.4.5.2. Financials
14.4.5.3. Developments
14.4.5.4. Strategic Outlook
14.4.6. Nitto Denko
14.4.6.1. Overview
14.4.6.2. Financials
14.4.6.3. Developments
14.4.6.4. Strategic Outlook
14.4.7. Teikoku Seiyaku
14.4.7.1. Overview
14.4.7.2. Financials
14.4.7.3. Developments
14.4.7.4. Strategic Outlook
14.4.8. GSK
14.4.8.1. Overview
14.4.8.2. Financials
14.4.8.3. Developments
14.4.8.4. Strategic Outlook
14.4.9. Luye Pharma Group
14.4.9.1. Overview
14.4.9.2. Financials
14.4.9.3. Developments
14.4.9.4. Strategic Outlook
14.4.10. Pfizer
14.4.10.1. Overview
14.4.10.2. Financials
14.4.10.3. Developments
14.4.10.4. Strategic Outlook
14.4.11. Teva Pharmaceutical
14.4.11.1. Overview
14.4.11.2. Financials
14.4.11.3. Developments
14.4.11.4. Strategic Outlook
14.4.12. Dr Reddys Laboratories
14.4.12.1. Overview
14.4.12.2. Financials
14.4.12.3. Developments
14.4.12.4. Strategic Outlook
14.4.13. Bayer
14.4.13.1. Overview
14.4.13.2. Financials
14.4.13.3. Developments
14.4.13.4. Strategic Outlook
14.4.14. Mundipharma
14.4.14.1. Overview
14.4.14.2. Financials
14.4.14.3. Developments
14.4.14.4. Strategic Outlook
14.4.15. Lohmann Therapie-Systeme
14.4.15.1. Overview
14.4.15.2. Financials
14.4.15.3. Developments
14.4.15.4. Strategic Outlook
14.4.16. Beijing Tide Pharmaceutical
14.4.16.1. Overview
14.4.16.2. Financials
14.4.16.3. Developments
14.4.16.4. Strategic Outlook
14.4.17. COMPANY 17
14.4.17.1. Overview
14.4.17.2. Financials
14.4.17.3. Developments
14.4.17.4. Strategic Outlook
14.4.18. COMPANY 18
14.4.18.1. Overview
14.4.18.2. Financials
14.4.18.3. Developments
14.4.18.4. Strategic Outlook
14.4.19. COMPANY 19
14.4.19.1. Overview
14.4.19.2. Financials
14.4.19.3. Developments
14.4.19.4. Strategic Outlook
14.4.20. COMPANY 20
14.4.20.1. Overview
14.4.20.2. Financials
14.4.20.3. Developments
14.4.20.4. Strategic Outlook